Antiviral property and mode of action of a sulphated polysaccharide from Sargassum patens against herpes simplex virus type 2

International Journal of Antimicrobial Agents

Volumn 24, Issue 3, 2004, Pages 279-283

  Zhu, W ^a   Chiu, L C M ^a   Ooi, V E C ^a   Chan, P K S ^a   Ang Jr , P O ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Genital herpes; HSV 2; Sargassum patens; Sulphated polysaccharide

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; POLYSACCHARIDE;

ALGA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CHOICE; DRUG MECHANISM; HERPES SIMPLEX VIRUS 2; NONHUMAN; PRIORITY JOURNAL; VIRUS ADSORPTION; VIRUS ISOLATION; VIRUS REPLICATION; ADSORPTION; CHEMISTRY; DRUG EFFECT; ISOLATION AND PURIFICATION; PHYSIOLOGY; SARGASSUM; VIRION; VIRUS CULTURE; VIRUS INACTIVATION;

SARGASSUM PATENS;

ADSORPTION; ANTIVIRAL AGENTS; HERPESVIRUS 2, HUMAN; PLAQUE ASSAY; POLYSACCHARIDES; SARGASSUM; VIRION; VIRUS INACTIVATION; VIRUS REPLICATION;

EID: 4344688687     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.02.022     Document Type: Article

References (27)

1. Alexander N.J. Barriers to sexually transmitted disease. Sci. Am. 3/4:1996;32-40
2. Gerbase A.C., Rowley J.T., Mertens T.E. Global epidemiology for sexually transmitted disease. Lancet. 351(Suppl 3):1998;2-4
3. Kalinyak J.E., Fleagle G., Docherty J.J. Incidence and distribute of herpes simplex virus type 1 and type 2 from genital lesions in college women. J. Med. Virol. 3:1977;175-181
4. Arvin A.M., Prober C.G. Herpes simplex virus type 2 - a persistent problem. New Engl. J. Med. 337:1997;1158-1159
5. Fleming D.T., McQuillan G.M., Johnson R.E. Herpes simplex virus type 2 in the United States, 1976-1994. New Engl. J. Med. 337:1997;1105-1111
6. Nahmias AJ, Lee FK, Beckman NS, Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world, Scotland. J Infect Dis 1990;(Suppl 69):19-36.
7. Reeves W.C., Corey L., Adams H.G., Vontver L.A., Holmes K.K. Risk of recurrence after first episodes of genital herpes: relation to HSV type and antibody response. New Engl. J. Med. 305:1981;315-319
8. Whitley RJ, Roizman B, Herpes simplex viruses. In: Richman DD, Whitley RJ, Hayden Jr FG, editors. Clinical virology. New York: Churchill Livingstone; 1997.
9. Engel J.P. Long-term suppression of genital herpes. JAMA. 280:1998;928-929
10. Hammer SM, Inouye RT, Antiviral agents. In: Richman DD, Whitely RJ, Hayden Jr FG, editors. Clinical virology. New York: Churchill Livingstone; 1997.
11. Becker Y. Antiviral agents from natural sources. Pharmacol. Ther. 10:1980;119-159
12. Harmsen M.C., Swart P.J., De Bethune M.P., et al. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against human immunodeficiency virus and human cytomegalovirus replication in vitro. J. Infect. Dis. 172:1995;307-312
13. Logu A.D., Loy G., Pellerano M.L., Bonsignore L., Schivo M.L. Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil. Antivi. Res. 48:2000;177-185
14. Baba M., Snoeck R., Pauwels R., De Clercq E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus and human immunodeficiency virus. Antimicrob. Agents Chemother. 32:1988;1742-1745
15. Schols D., De Clercq E., Balzarini J., et al. Sulphated polymers are potent and selective inhibitors of various enveloped viruses including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, respiratory syncytial virus, and toga-, arena- and retroviruses. Antivir. Chem. Chemother. 1:1990;233-240
16. Damonte E., Neyts J., Pujol C.A., et al. Antiviral activity of a sulphated polysaccharide from the red seaweed Nothogenia fastigita. Biochem. Pharmacol. 12:1994;2187-2192
17. Witvrouw M., Desmyter J., De Clercq E. Polysulfates as inhibitors of HIV and other enveloped viruses. Antivir. Chem. Chemother. 5:1994;345-359
18. Witvrouw M., Este J.A., Mateu M.E., et al. Activity of a sulfated polysaccharide extracted from the red seaweed Aghardhiella tenera against human immunodeficiency virus and other enveloped viruses. Antivir. Chem. Chemother. 5:1994;297-303
19. Zacharopoulos V.R., Phillips D.M. Vaginal formulations of carrageenan protect mice from herpes simplex virus infection. Clin. Diagn. Lab. Immunol. 4:1997;465-468
20. Zhu W., Ooi V.E.C., Chan P.K.S., Ang P.O. Jr. Isolation and characterization of a sulfated polysaccharide from the brown alga Sargassum patens and determination of its anti-herpes activity. Biochem. Cell Biol. 81:2003;25-33
21. Shigeta S., Mori S., Baba M., et al. Antiviral activities of ribavirin, 5-ethynyl-1-D-ribofuranosylimidazole-4-carboxamide, and 6′-(R)-6′-C- methylneplanocin A against several ortho- and paramyxoviruses. Antimicrob. Agents Chemother. 36:1992;435-439
22. Barnard D.L., Huffman J.H., Morris J.L.B., Wood S.G., Hughes B.G., Sidwell R.W. Evaluation of the antiviral activity of anthraquinones anthrones and anthraquinone against human cytomegalovirus. Antivir. Res. 17:1992;63-77
23. Galasso GJ, Whitely RJ, Merigan TC, Antiviral agents and human viral diseases. Philadelphia: Lippincott-Raven Publishers; 1997.
24. Eo S.K., Kim Y.S., Lee C.K., Han S.S. Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J. Ethnopharmacol. 72:2000;475-481
25. Gonzalez M.E., Alarcon B., Carraasco L. Polysaccharides as antiviral agents: antiviral activity of carrageenan. Antimicrob. Agents Chemother. 31:1987;1388-1393
26. Lee J.B., Hayashi K., Hayashi T., Sankawa U., Maeda M. Antiviral activities against HSV-1, HCMV and HIV-1 of Rhamnan sulfate from Monostroma latissimum. Planta Med. 65:1999;439-441
27. Hoshino T., Hayashi T., Hayashi K., Hamada J., Lee J.B., Sankawa U. An antivirally active sulphated polysaccharide from Sargassum horneri. Biol. Pharm. Bull. 21:1999;730-734